Navigation Links
Microplate Washers - EL401 Manual Washer

ProductsMicroplate Washers - EL401 Manual Washer
Company Bio-Tek Instruments, Inc.
Item Microplate Washers - EL401 Manual Washer
Features 5 wash/aspirate cycles in 5 seconds, one row at a time. Gravity-fed, user-controlled fill volumes with convenient finger-controlled valve. Overflow protection for flat and U-bottom polystyrene microplates. Continuous aspiration and user controllable dispense valve. All chemically-resistant coatings and materials; readily cleaned and completely autoclavable.
Description The EL401 Manual Plate/Strip Washer accommodates all 96-well microplates and microwell strips. The unique alignment mechanism allows quick and accurate positioning of the 8- or 12-channel manifold above the row to be washed. The EL401 aspirates the wells continuously. The entire washer and alignment mechanism can be readily cleaned or autoclaved, and the overflow protection guards against overfilling.
Info Bio-Tek Instruments, Inc.
Customer Service: (888) 451-5171

Related medicine products :

1. Microplate washer MP-1200 (220 V/ 50 Hz)
2. MW 96 Microplate Washer
3. Microplate washer MP-1200 (110 V/ 60 Hz)
4. Microplate Washers - ELx50 96-/384-Well Auto Strip Washer
5. Microplate Washers - ELx405 Microplate Washer
6. Microplate ELISA Washers - Manual Microplate Washer
7. Microplate ELISA Washers - Automated Microplate Washer
8. PW 40 Microplate Washers
9. PW 41 Microplate Washers
10. Model 1575 Immunowash Microplate Washer
11. Model 1575 Microplate Washer
Spherical Burr for FR030R, 5 mm.
Hough Hough Burr-Saw for Crurotomy, 1 mm, ISO-No. 010.
...REK, An Precise placement integrated with the CRW ... Accudrive offers a unique off-board cable drive m... without the problem of fluid leakage. The modular...s and simplified removal during deep brain stimula...
Images from DP micro video cameras can be displayed on high quality 14 ins and 20 ins color monitors, which offer superior picture performance and effective operation functions.
Medicine Products:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... called the H9N2 infection is reported in a nine m...Controller of the Center// for Health Protection o...s is the first of its kind in the past three years...y had fever from March 4 and she was hospitalized ...
...y come to the therapeutic aid of chronic lower bac...The School of Materials// and Professor Tony Freem.... The tiny gel particles discovered by the team a...jected into the damaged region. This study was per...
...ts that inflammation associated with the progressi...stasis of prostate cancer.// According to this r... San Diego (UCSD) School of Medicine "mounting an ...r body fight the cancer" may not be a good thing. ...
...at involves measuring the distance between the upp...lastic surgeons// use computer imaging software, a... facial proportions has been studied for centuries...d dentists,” the authors write as background infor...
Other Medicine News:Health News:Inflammation Promotes Metastasis of Prostate Cancer 2Health News:Inflammation Promotes Metastasis of Prostate Cancer 3Health News:Computer Imaging Assists With Facial Reconstructive Surgery 2
(Date:10/8/2008)... Reduce Animal Use in Cosmetics and Chemicals Test...k Corp. today announced,that results of a recently...-up" validation study on MatTek,s EpiDerm in vitro...monstrated the required sensitivity and,specificit...ative to animal,testing for determining human skin...
(Date:10/8/2008)... Program to be Discontinued and Headcount to be Re...s Portfolio Review; Zanolimumab Program to be Dis...f Employees, COPENH.../S (OMX: GEN),announced today that it is discontin... addition, as a result of a portfolio review and,a...
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/7/2008)... 7 /- Prometheus Laboratories Inc., a... findings from its,development of PROMETHEUS(R) IB...ritable bowel syndrome (IBS). The findings suggest...cular biomarkers in blood samples,between IBS and ...arkers,combined with a proprietary algorithm, led...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Conscientious People Less Prone to Alzheimers 2508 1Conscientious People Less Prone to Alzheimers 2508 2Conscientious People Less Prone to Alzheimers 2508 3OPKO Health Appoints Pascal J Goldschmidt to Board of Directors 2506 1OPKO Health Appoints Pascal J Goldschmidt to Board of Directors 2506 2OPKO Health Appoints Pascal J Goldschmidt to Board of Directors 2506 3Todays 2008 Medicare Part B Premium Announcement is Not Good News 2504 1Todays 2008 Medicare Part B Premium Announcement is Not Good News 2504 2Regence Expands MedAdvantage Market Hits the Road to Educate Seniors 2502 1Regence Expands MedAdvantage Market Hits the Road to Educate Seniors 2502 2Regence Expands MedAdvantage Market Hits the Road to Educate Seniors 2502 3
...t Generation Renin Inhibitor to Continue Phase II ...and and BRIDGEWATER NJ/USA, 28 June 2007-Speedel,(...ther significant,milestone in the development of i...completion of a Phase IIa proof-of-concept clinica...ion. Based on these,positive results, the company ...
...KHAM, ON, June 28, 2007 /PRNewswire/ - Cytochroma ...clinical trial of,CTA018 Injection. The initial to...was safe and well tolerated. Complete study,result...leted Phase I trial was an open label,placebo-con...nistered to 20 healthy volunteers. In this trial, ...
Other Medicine Technology:Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 2Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 3Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 4Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 5Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 6Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 7Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 8Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3